藥物交互作用
Denosumab + Efgartigimod alfa
嚴重程度: 中度
Denosumab and Efgartigimod alfa: moderate interaction.
最後更新
僅供醫療專業人員參考。本頁為簡要摘要，並非醫療建議，亦不能取代官方仿單或臨床判斷。開立處方或調劑前請務必核實。
本頁的臨床內容僅提供英文版。
摘要
Efgartigimod blocks the neonatal Fc receptor, which recycles IgG and protects it from degradation. Denosumab is an IgG2 antibody, so its exposure and bone-protective effect could theoretically fall. Clinical data are lacking.
用白話說明這項交互作用的意義
Denosumab and Efgartigimod alfa can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.
Denosumab belongs to Oncology; Efgartigimod alfa belongs to Miscellaneous.
為什麼會發生
FcRn blockade accelerates IgG catabolism and may lower denosumab concentrations.
處置方式
Monitor bone turnover markers and bone density response, and watch for loss of effect such as rising resorption markers. If denosumab is essential long term, consider the timing of efgartigimod cycles or alternative antiresorptives.
可向藥師詢問的問題
- Should I take them at different times of day?
- Does the dose of either medicine need to change?
- Is there anything I should avoid, such as alcohol or certain foods, while on both?
Denosumab 的其他交互作用
Efgartigimod alfa 的其他交互作用
常見問題
Can I take Denosumab with Efgartigimod alfa?
MediHelp rates the interaction as moderate. Denosumab and Efgartigimod alfa can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Efgartigimod blocks the neonatal Fc receptor, which recycles IgG and protects it from degradation. Denosumab is an IgG2 antibody, so its exposure and bone-protective effect could theoretically fall. Clinical data are lacking.
How serious is the interaction between Denosumab and Efgartigimod alfa?
MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor bone turnover markers and bone density response, and watch for loss of effect such as rising resorption markers. If denosumab is essential long term, consider the timing of efgartigimod cycles or alternative antiresorptives.
What other medicines interact with Denosumab?
MediHelp also lists interactions of Denosumab with, for example, Abatacept, Adalimumab, Alefacept. The full list is on the Denosumab page.
在 MediHelp App 中取得完整藥品專論、劑量資訊與交互作用檢查
在 MediHelp App 中開啟完整參考資料、檢查多種藥物間的交互作用，並使用劑量工具。
